{"gene":"NDUFA13","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"NDUFA13/GRIM-19 was identified as a bona fide subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I), specifically residing in the hydrophilic arm (subcomplex Iλ). The intact protein is N-terminally acetylated.","method":"Denaturing gel electrophoresis of purified complex I subcomplex, tryptic digestion, mass spectrometric peptide sequencing, cDNA cloning, intact protein mass measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical identification from purified complex I by mass spectrometry and sequencing; foundational subunit assignment replicated by subsequent studies","pmids":["11522775"],"is_preprint":false},{"year":2000,"finding":"GRIM-19 is required for IFN-β/retinoic acid-induced tumor cell death; antisense ablation confers resistance to this death stimulus, and overexpression enhances cell death. The protein was initially characterized as a nuclear protein whose expression is induced by the IFN/RA combination.","method":"Antisense cDNA knockout genetic screen, antisense overexpression survival assay, overexpression cell death assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide genetic screen with functional validation by overexpression and antisense in same study; single lab","pmids":["10924506"],"is_preprint":false},{"year":2003,"finding":"GRIM-19 physically interacts specifically with STAT3 (but not STAT1 or STAT5a) via yeast two-hybrid and co-immunoprecipitation in multiple cell types. GRIM-19 co-localizes with mitochondrial markers, forms perinuclear aggregates with co-expressed STAT3, inhibits STAT3 nuclear translocation stimulated by EGF, and represses STAT3 transcriptional activity and target gene expression.","method":"Yeast two-hybrid screen, co-immunoprecipitation, domain mapping, confocal microscopy co-localization, reporter gene assay, cell growth suppression assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal methods (Y2H, Co-IP, imaging, reporter), replicated independently by PMID 12867595","pmids":["12628925"],"is_preprint":false},{"year":2003,"finding":"GRIM-19 binds STAT3 and inhibits its transcriptional activity without blocking ligand-induced STAT3 activation or DNA binding. Mutational analysis showed that the transactivation domain of STAT3, especially residue S727, is required for GRIM-19 binding. GRIM-19 does not inhibit STAT1.","method":"Yeast two-hybrid screen, co-immunoprecipitation, mutational analysis, transcription reporter assays, EMSA","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus mutagenesis plus functional assays, independently replicated across two labs (PMID 12628925 and 12867595)","pmids":["12867595"],"is_preprint":false},{"year":2004,"finding":"GRIM-19 is essential for mitochondrial complex I assembly and electron transfer activity. GRIM-19 knockout mice die at embryonic day 9.5, and GRIM-19−/− blastocysts show abnormal mitochondrial structure, morphology, and distribution. Deletion of GRIM-19 destroys complex I assembly and electron transfer activity and influences other respiratory chain complexes.","method":"Gene targeting/knockout mouse generation, native complex I activity assays, electron microscopy of mitochondria, blue native PAGE for complex assembly","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse with defined biochemical phenotype (complex I assembly and activity), multiple orthogonal methods, independently consistent with PMID 11522775","pmids":["15367666"],"is_preprint":false},{"year":2008,"finding":"GRIM-19 is required for maintenance of mitochondrial membrane potential (ΔΨm). Domain dissection showed the N-terminal sequence contains the mitochondrial localization signal, and deletions of residues 70–80, 90–100, or the entire C-terminal region (70–144) abolished ΔΨm without this effect being shared by other complex I subunits (NDUFA9, NDUFS3). Deletion of the last 10 residues prevented assembly into complex I. A dominant-negative mutant (N-terminal 60 aa + last 10 aa C-terminal) assembled into complex I but failed to maintain ΔΨm and sensitized cells to apoptosis.","method":"Deletion/truncation/point mutagenesis, mitochondrial membrane potential assays (JC-1), blue native PAGE for complex I assembly, apoptosis assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with in-cell functional readout (ΔΨm, complex assembly), multiple mutants and controls in single study","pmids":["18287540"],"is_preprint":false},{"year":2002,"finding":"KSHV vIRF1 directly interacts with GRIM-19 via its N-terminal region, colocalizes with GRIM-19 in cells, and deregulates GRIM-19-induced apoptosis, conferring resistance to IFN/RA-induced cell death. HPV16 E6 also binds GRIM-19.","method":"Yeast two-hybrid assay, co-immunoprecipitation in vivo, in vitro binding assay, confocal colocalization, cell death assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus in vitro binding plus functional death assay; single lab","pmids":["12163600"],"is_preprint":false},{"year":2005,"finding":"GRIM-19 interacts with NOD2 in intestinal epithelial cells (HT29) and is required for NF-κB activation downstream of NOD2-mediated recognition of muramyl dipeptide (MDP). GRIM-19 also controls pathogen invasion of intestinal epithelial cells.","method":"Yeast two-hybrid screen, co-immunoprecipitation with endogenous NOD2, NF-κB reporter assay, bacterial invasion assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — endogenous Co-IP, functional NF-κB and invasion assays; single lab","pmids":["15753091"],"is_preprint":false},{"year":2007,"finding":"GRIM-19 physically interacts with the mitochondrial serine protease HtrA2, augments HtrA2-driven destruction of the antiapoptotic protein XIAP in an IFN/RA-dependent manner, and promotes cell death. The KSHV oncoprotein vIRF1 disrupts this GRIM-19–HtrA2 interaction.","method":"Yeast two-hybrid screen, co-immunoprecipitation, XIAP degradation assay, cell death assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional substrate (XIAP) assay; single lab","pmids":["17297443"],"is_preprint":false},{"year":2007,"finding":"GRIM-19 suppresses v-Src-induced oncogenic transformation by down-regulating STAT3-dependent gene expression and also inhibits src-induced tyrosyl phosphorylation of focal adhesion kinase (FAK), paxillin, E-cadherin, and γ-catenin independently of STAT3.","method":"Overexpression and shRNA knockdown, in vitro transformation assays, in vivo tumor xenografts, phosphotyrosine immunoblotting","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays in vitro and in vivo with specific molecular readouts; single lab","pmids":["17823279"],"is_preprint":false},{"year":2007,"finding":"The HHV-6B U95 immediate-early protein interacts with GRIM-19. This interaction was verified by Co-IP and confocal coimmunolocalization. Silencing U95 by RNAi reduced viral load and abrogated the loss of mitochondrial membrane potential caused by HHV-6B infection.","method":"Yeast two-hybrid screening, co-immunoprecipitation, confocal microscopy co-localization, RNA interference knockdown, mitochondrial membrane potential assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus RNAi functional rescue; single lab","pmids":["17928352"],"is_preprint":false},{"year":2009,"finding":"GRIM-19 inhibits v-Src-induced cell motility by suppressing podosome formation (cytoskeletal remodeling). The N-terminus of GRIM-19 is critical for this function. Tumor-associated GRIM-19 mutations disrupted inhibition of cell motility independently of STAT3.","method":"Overexpression of wild-type and mutant GRIM-19, podosome/actin imaging, cell motility assays, in vivo metastasis assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with defined mutants; in vitro and in vivo; single lab","pmids":["19151760"],"is_preprint":false},{"year":2012,"finding":"GRIM-19 acts as a chaperone to recruit STAT3 into mitochondria, where STAT3 resides in the inner mitochondrial membrane. In vitro import assays showed GRIM-19 enhances integration of STAT3 into complex I. The S727A mutation in STAT3 reduces its import and assembly even in the presence of GRIM-19.","method":"In vitro mitochondrial import assay, mitochondrial fractionation (inner membrane localization), blue native PAGE for complex I assembly, S727A STAT3 mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted import assay plus mutagenesis plus organelle fractionation; multiple orthogonal methods in one study","pmids":["23271731"],"is_preprint":false},{"year":2012,"finding":"During TNF-induced necroptosis, RIPK1-dependent phosphorylation of STAT3 on serine 727 induces STAT3 interaction with GRIM-19, leading to translocation of STAT3 to mitochondria, increased mitochondrial ROS production, and cell death.","method":"Co-immunoprecipitation, RIPK1 knockdown/necrostatin-1 inhibition, mitochondrial fractionation, ROS measurement, cell viability assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating STAT3-GRIM-19 interaction conditioned on phosphorylation, with functional knockdown validation; single lab","pmids":["22393233"],"is_preprint":false},{"year":2012,"finding":"GRIM-19 heterozygous knockout mice have compromised complex I activity and increased ROS in macrophages. Bacterial infection induces rapid upregulation of GRIM-19 and complex I activity in wild-type macrophages; GRIM-19+/− macrophages have decreased intracellular bacterial killing (defect in phagosome-lysosome fusion) and reduced proinflammatory cytokine production (IL-1, IL-12, IL-6, IFN-γ).","method":"Heterozygous knockout mouse, complex I activity assay, ROS measurement, bacterial killing assay, phagosome fusion assay, ELISA for cytokines","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO model with multiple defined biochemical and cellular phenotypes; mechanistically links complex I activity to innate immune function","pmids":["22665480"],"is_preprint":false},{"year":2011,"finding":"GRIM-19 disrupts the HPV E6/E6AP complex by physically interacting (via its N-terminus) with both E6 and E6AP; GRIM-19 promotes E6AP ubiquitination and degradation, thereby protecting p53 from E6-mediated degradation and inducing apoptosis in cervical cancer cells.","method":"Co-immunoprecipitation, GST pull-down assay, competition pull-down, in vivo and in vitro ubiquitination assay, xenograft mouse model","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus GST pull-down plus ubiquitination assay plus in vivo validation; single lab","pmids":["21765936"],"is_preprint":false},{"year":2013,"finding":"Tumor-derived somatic mutations in GRIM-19 (L71P, L91P, A95T) significantly impair GRIM-19's ability to associate with STAT3, block gene expression, suppress cellular transformation, and prevent metastasis in head and neck tumors.","method":"Tumor sequencing, co-immunoprecipitation with mutants, reporter assays, in vitro transformation assay, in vivo tumor growth and metastasis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis with multiple readouts in vitro and in vivo; single lab","pmids":["23386605"],"is_preprint":false},{"year":2013,"finding":"Monoallelic (heterozygous) loss of GRIM-19 in mouse skin promotes chemical carcinogenesis and formation of invasive squamous cell carcinomas, with high Stat3 activity, increased Stat3-responsive gene expression, mitochondrial electron transport dysfunction, failure to assemble ETC complexes, and altered glycolytic gene expression.","method":"Conditional skin-specific knockout mouse, chemical carcinogenesis protocol, blue native PAGE for ETC assembly, STAT3 reporter assay, metabolic gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional KO with multiple mechanistic readouts; defines haploinsufficiency as tumor-suppressor mechanism","pmids":["24145455"],"is_preprint":false},{"year":2013,"finding":"GRIM-19 downregulation in glioblastoma promotes HIF1α accumulation in a STAT3-dependent manner; GRIM-19 loss allows STAT3 to act as a competitive inhibitor of pVHL–HIF1α interaction, preventing pVHL-mediated ubiquitination and proteasomal degradation of HIF1α, thereby promoting metabolic reprogramming toward glycolysis.","method":"shRNA knockdown, overexpression, co-immunoprecipitation (STAT3–pVHL–HIF1α), proteasome inhibitor treatment, HIF1α stability assay, metabolic assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating molecular complex plus functional degradation assay; single lab","pmids":["23580587"],"is_preprint":false},{"year":2015,"finding":"A germline pathogenic mutation in NDUFA13/GRIM-19 causes drastic reduction in complex I enzymatic activity in patient muscle biopsies and decreased complex I-driven respiration in fibroblasts (with preserved complex II, III, IV activities). Western blots showed decreased NDUFA13 protein, complex I holoenzyme, and supercomplexes in mitochondrial fractions. Silencing NDUFA13 in control cells reproduced the complex I instability.","method":"Next-generation sequencing, complex I enzymatic activity assay, oxygen consumption in fibroblasts, blue native PAGE/western blot for complex I and supercomplexes, siRNA knockdown in control cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct biochemical activity measurements in patient tissue plus siRNA phenocopy; multiple orthogonal methods","pmids":["25901006"],"is_preprint":false},{"year":2017,"finding":"Cardiac-specific heterozygous knockout of NDUFA13 in mice yields normal cardiac function at baseline but resistance to ischemia-reperfusion injury. At basal state, cHet mice exhibit higher cytosolic H2O2 (but not mitochondrial). This H2O2 acts as a second messenger driving STAT3 dimerization and antiapoptotic signaling, resulting in suppressed superoxide burst and decreased infarct size during I/R.","method":"Cardiac-specific tamoxifen-inducible NDUFA13 KO mouse, I/R model, oxygen consumption rate assay, H2O2 measurement (cytosolic vs mitochondrial), STAT3 dimerization assay, infarct size measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo cardiac KO with mechanistic ROS/STAT3 signaling dissection using multiple orthogonal methods; single lab","pmids":["29078279"],"is_preprint":false},{"year":2021,"finding":"GRIM-19 induces apoptosis in colorectal cancer cells in a p53-dependent manner via the SIRT7/PCAF/MDM2 axis: GRIM-19 activates SIRT7, which triggers PCAF-mediated ubiquitination of MDM2, stabilizing p53 protein.","method":"Overexpression/knockdown, co-immunoprecipitation, ubiquitination assay, flow cytometry for apoptosis, in vivo xenograft","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus in vivo validation; single lab","pmids":["34461110"],"is_preprint":false},{"year":2018,"finding":"GRIM19 co-localizes with Bcl-xL in the mitochondria of bladder cancer cells. GRIM19 overexpression promotes Bcl-xL polyubiquitination and degradation via p38-MAPK and JNK pathways, contributing to cisplatin sensitization; inhibition of Bcl-xL rescues GRIM19 deficiency-caused cisplatin resistance.","method":"Co-immunoprecipitation, confocal colocalization, ubiquitination assay, kinase inhibitor experiments (p38/JNK), stable GRIM19 knockdown cell lines, xenograft mouse model","journal":"Cancer chemotherapy and pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating GRIM19–Bcl-xL interaction plus ubiquitination assay plus pharmacological pathway dissection; single lab","pmids":["30032449"],"is_preprint":false},{"year":2022,"finding":"GRIM-19/NDUFA13 is a binding partner of mycobacterial Zmp1 metalloprotease. GRIM-19 is required for NLRP3 inflammasome activation: CRISPR/Cas9 knockout of GRIM-19 in macrophages abolishes IL-1β production in response to mycobacterial infection and to NLRP3 activators (ATP, nigericin). GRIM-19 is required for mitochondrial ROS generation and NLRP3-dependent caspase-1 activation. Forced Zmp1 expression or GRIM-19 loss decreases mitochondrial membrane potential.","method":"CRISPR/Cas9 knockout macrophage line, IL-1β ELISA, caspase-1 activity assay, mitochondrial ROS measurement, mitochondrial membrane potential assay, Zmp1 overexpression","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with multiple defined biochemical phenotypes; mechanistically positions GRIM-19 upstream of NLRP3/caspase-1/IL-1β pathway","pmids":["34907600"],"is_preprint":false},{"year":2020,"finding":"GRIM-19 deficiency in gastric cancer cells triggers ROS-dependent activation of the NRF2-HO-1 axis, which drives metastasis. HO-1 inhibition reverses both GRIM-19 deficiency-driven NRF2 activation and NRF2 activator-induced NRF2 signaling via a positive-feedback NRF2-HO-1 loop.","method":"CRISPR/Cas9 lentivirus gene editing, in vivo metastasis mouse models, ROS inhibitor/NRF2 inhibitor/HO-1 inhibitor pharmacological intervention, reporter gene assay, flow cytometry","journal":"Gastric cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO plus pharmacological pathway dissection plus in vivo validation; single lab","pmids":["32770429"],"is_preprint":false},{"year":2010,"finding":"A structural motif in the N-terminus of GRIM-19 is required for its interaction with STAT3 and antitumor activity; disruption of specific amino acids within this motif (including a clinically observed mutation) weakens STAT3 binding and abolishes growth-suppressive function.","method":"Mutational analysis, co-immunoprecipitation, reporter assays, transformation assays","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis with binding and functional readouts; single lab","pmids":["20595633"],"is_preprint":false},{"year":2016,"finding":"GRIM-19 knockdown in Jurkat cells increases intracellular ROS and p-mTOR expression; NAC (ROS inhibitor) reverses p-mTOR upregulation from GRIM-19 loss, placing GRIM-19 upstream of a ROS–mTOR signaling axis that regulates Treg/Th17 balance.","method":"siRNA knockdown, intracellular ROS measurement (DCFH-DA), western blot for p-mTOR, NAC rescue experiment","journal":"Molecular human reproduction","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, indirect pathway inference via ROS/NAC rescue; limited mechanistic depth","pmids":["29741731"],"is_preprint":false},{"year":2024,"finding":"GRIM-19 overexpression increases mitochondrial STAT3 (mitoSTAT3) levels, induces mitophagy, and alleviates fibrosis in an SSc model. GRIM-19 directly binds STAT3 and recruits it to mitochondria via the mitochondrial importer Tom20.","method":"Overexpression in murine SSc model, mitochondrial STAT3 quantification, mitophagy assay, Tom20 co-immunoprecipitation, in vivo bleomycin SSc model","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP (Tom20), in vivo model plus in vitro mechanistic assays; single lab","pmids":["39643607"],"is_preprint":false}],"current_model":"NDUFA13/GRIM-19 is an essential accessory subunit of the mitochondrial respiratory chain complex I (residing in the hydrophilic arm) that is required for complex I assembly, electron transfer activity, and maintenance of mitochondrial membrane potential; beyond its bioenergetic role, it functions as a specific inhibitor of STAT3 by direct physical interaction (via its N-terminal domain binding the STAT3 transactivation domain, dependent on S727) that blocks STAT3 nuclear translocation and transcriptional activity, and also acts as a chaperone recruiting STAT3 to the inner mitochondrial membrane via Tom20; it additionally interacts with HtrA2 to augment XIAP degradation, with NOD2 to enable NF-κB activation, and is required for mitochondrial ROS generation upstream of NLRP3 inflammasome/caspase-1/IL-1β activation, while tumor-derived mutations in its N-terminal structural motif selectively abrogate STAT3 binding and anti-oncogenic functions."},"narrative":{"mechanistic_narrative":"NDUFA13/GRIM-19 is an essential accessory subunit of the hydrophilic arm of mitochondrial NADH:ubiquinone oxidoreductase (complex I) that couples respiratory chain bioenergetics to apoptotic and inflammatory signaling [PMID:11522775, PMID:15367666]. As a structural subunit it is required for complex I assembly, electron transfer activity, and maintenance of the mitochondrial membrane potential, with its N-terminal sequence providing the mitochondrial localization signal and its C-terminal region required for both assembly into complex I and membrane potential maintenance; its loss destabilizes complex I holoenzyme and supercomplexes and is embryonic-lethal in mice [PMID:15367666, PMID:18287540, PMID:25901006]. A germline pathogenic NDUFA13 mutation causes an isolated complex I deficiency in patients, with reduced NDUFA13 protein, complex I, and supercomplexes [PMID:25901006]. Beyond bioenergetics, GRIM-19 was identified as a mediator of IFN-β/retinoic acid-induced tumor cell death [PMID:10924506] and functions as a specific inhibitor of STAT3: it binds STAT3 (but not STAT1 or STAT5a) through a structural motif in its N-terminus that engages the STAT3 transactivation domain in an S727-dependent manner, blocking STAT3 nuclear translocation and transcriptional activity without preventing STAT3 activation or DNA binding [PMID:12628925, PMID:12867595, PMID:20595633]. It also acts as a chaperone recruiting STAT3 into the inner mitochondrial membrane via Tom20 and integrating it into complex I [PMID:23271731, PMID:39643607]. Through these activities GRIM-19 functions as a tumor suppressor: monoallelic loss promotes STAT3-driven carcinogenesis, and tumor-derived N-terminal mutations (L71P, L91P, A95T) selectively abrogate STAT3 binding and anti-oncogenic functions [PMID:23386605, PMID:24145455]. GRIM-19 additionally couples complex I-dependent mitochondrial ROS to innate immunity, being required for NLRP3 inflammasome/caspase-1/IL-1β activation and bactericidal macrophage function [PMID:22665480, PMID:34907600], and engages partners including HtrA2 (augmenting XIAP degradation) and NOD2 (enabling NF-κB activation) [PMID:15753091, PMID:17297443]. Multiple viral oncoproteins (KSHV vIRF1, HPV16 E6, HHV-6B U95) target GRIM-19 to subvert its apoptotic and bioenergetic functions [PMID:12163600, PMID:17928352, PMID:21765936].","teleology":[{"year":2000,"claim":"Before any molecular role was known, a functional screen established GRIM-19 as a required mediator of cytokine-induced tumor cell death, framing it as a candidate cell-death effector rather than a housekeeping protein.","evidence":"Antisense cDNA knockout genetic screen with overexpression and survival validation in IFN-β/retinoic acid-treated tumor cells","pmids":["10924506"],"confidence":"Medium","gaps":["Did not identify the biochemical activity underlying death induction","Initial nuclear localization claim not reconciled with later mitochondrial assignment"]},{"year":2001,"claim":"Direct biochemical identification placed GRIM-19 in the respiratory machinery, establishing it as a bona fide complex I subunit in the hydrophilic arm.","evidence":"Mass spectrometric sequencing of purified bovine complex I subcomplex Iλ plus cDNA cloning and intact mass measurement","pmids":["11522775"],"confidence":"High","gaps":["Did not test whether the subunit is required for assembly or activity","Connection to the death phenotype not yet made"]},{"year":2003,"claim":"Two independent studies converged to define GRIM-19 as a specific STAT3 inhibitor, mapping the interaction to the STAT3 transactivation domain and S727 and showing repression of transcription without blocking activation or DNA binding.","evidence":"Yeast two-hybrid, reciprocal co-immunoprecipitation, domain/point mutagenesis, reporter assays, EMSA and confocal imaging across multiple cell types","pmids":["12628925","12867595"],"confidence":"High","gaps":["Did not establish how a complex I subunit accesses STAT3","Structural basis of the S727-dependent interaction not resolved"]},{"year":2004,"claim":"Knockout demonstrated GRIM-19 is indispensable for complex I assembly and electron transfer and for embryonic viability, proving its bioenergetic role is essential rather than accessory.","evidence":"Gene-targeted knockout mouse (E9.5 lethality), blue native PAGE, native activity assays, and EM of blastocyst mitochondria","pmids":["15367666"],"confidence":"High","gaps":["Did not separate bioenergetic from STAT3-regulatory contributions to phenotype","Mechanism of assembly support not defined"]},{"year":2008,"claim":"Domain dissection separated GRIM-19's assembly role from membrane-potential maintenance, localizing the mitochondrial targeting signal to the N-terminus and identifying regions whose loss abolishes ΔΨm and sensitizes cells to apoptosis.","evidence":"Systematic deletion/truncation/point mutagenesis with JC-1 ΔΨm readout, blue native PAGE, and apoptosis assays including a dominant-negative mutant","pmids":["18287540"],"confidence":"High","gaps":["Did not define the molecular basis by which the C-terminal region maintains ΔΨm","Did not link ΔΨm maintenance to specific downstream signaling"]},{"year":2012,"claim":"Reconstituted import showed GRIM-19 chaperones STAT3 into the inner mitochondrial membrane and complex I, providing the physical mechanism by which the two interacting proteins co-reside in mitochondria.","evidence":"In vitro mitochondrial import assay, inner-membrane fractionation, blue native PAGE, and S727A STAT3 mutagenesis","pmids":["23271731"],"confidence":"High","gaps":["Functional consequence of mitochondrial STAT3 on complex I activity not quantified","Import receptor not identified in this study"]},{"year":2012,"claim":"GRIM-19 was placed in a death-signaling axis in which RIPK1-dependent S727 phosphorylation drives STAT3-GRIM-19 association, mitochondrial STAT3 translocation, and ROS-dependent necroptosis.","evidence":"Co-IP conditioned on phosphorylation, RIPK1 knockdown/necrostatin-1, mitochondrial fractionation, ROS and viability assays","pmids":["22393233"],"confidence":"Medium","gaps":["Single lab; reciprocal validation of the phospho-dependent interaction limited","Source of mitochondrial ROS not mechanistically isolated"]},{"year":2012,"claim":"A heterozygous knockout linked GRIM-19 dosage to innate immune competence, connecting reduced complex I activity and elevated macrophage ROS to defective bacterial killing and cytokine output.","evidence":"GRIM-19+/− mouse macrophages with complex I activity, ROS, bacterial killing, phagosome-lysosome fusion, and cytokine ELISA assays","pmids":["22665480"],"confidence":"High","gaps":["Did not define the downstream inflammasome step linking ROS to cytokines","Did not separate STAT3-dependent from bioenergetic contributions"]},{"year":2013,"claim":"In vivo and patient-derived genetics established GRIM-19 as a haploinsufficient tumor suppressor, with monoallelic loss promoting STAT3-driven carcinogenesis and tumor-derived N-terminal mutations selectively crippling STAT3 binding and anti-oncogenic function.","evidence":"Conditional skin knockout with chemical carcinogenesis, tumor sequencing of L71P/L91P/A95T mutants, co-IP, reporter, transformation and metastasis assays","pmids":["24145455","23386605"],"confidence":"High","gaps":["Relative contribution of ETC dysfunction versus STAT3 derepression to tumorigenesis not resolved","Whether mutations affect bioenergetic function not addressed"]},{"year":2022,"claim":"CRISPR knockout positioned GRIM-19 upstream of the NLRP3 inflammasome, showing it is required for mitochondrial ROS generation, caspase-1 activation, and IL-1β production, and that the mycobacterial protease Zmp1 targets it.","evidence":"CRISPR/Cas9 macrophage knockout with IL-1β ELISA, caspase-1 activity, mitochondrial ROS and ΔΨm assays, and Zmp1 overexpression","pmids":["34907600"],"confidence":"High","gaps":["Direct physical link between GRIM-19/complex I ROS and NLRP3 not structurally defined","Whether Zmp1 binding disrupts complex I or STAT3 functions untested"]},{"year":2024,"claim":"GRIM-19 was shown to recruit STAT3 to mitochondria via the import receptor Tom20 and to induce mitophagy in a fibrosis model, refining the chaperone mechanism with a named receptor.","evidence":"Overexpression in a murine systemic sclerosis model, Tom20 co-IP, mitochondrial STAT3 quantification, and mitophagy assays","pmids":["39643607"],"confidence":"Medium","gaps":["Single lab; reciprocal Tom20 validation limited","Link between mitoSTAT3 recruitment and mitophagy induction mechanistically incomplete"]},{"year":null,"claim":"How GRIM-19's structural role in complex I, its STAT3-sequestering activity, and its control of mitochondrial ROS are quantitatively partitioned across bioenergetic, apoptotic, and inflammatory outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the GRIM-19–STAT3 interface","Causal hierarchy between complex I dysfunction and each downstream signaling branch not established","Whether disease and tumor mutations act primarily through STAT3 or bioenergetics undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,4,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,25]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[12,27]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,4,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,4,12]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,8,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14,23]}],"complexes":["mitochondrial respiratory chain complex I"],"partners":["STAT3","HTRA2","NOD2","TOMM20","BCL2L1","UBE3A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9P0J0","full_name":"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13","aliases":["Cell death regulatory protein GRIM-19","Complex I-B16.6","CI-B16.6","Gene associated with retinoic and interferon-induced mortality 19 protein","GRIM-19","Gene associated with retinoic and IFN-induced mortality 19 protein","NADH-ubiquinone oxidoreductase B16.6 subunit"],"length_aa":144,"mass_kda":16.7,"function":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis (PubMed:27626371). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:27626371). Involved in the interferon/all-trans-retinoic acid (IFN/RA) induced cell death. This apoptotic activity is inhibited by interaction with viral IRF1. Prevents the transactivation of STAT3 target genes. May play a role in CARD15-mediated innate mucosal responses and serve to regulate intestinal epithelial cell responses to microbes (PubMed:15753091)","subcellular_location":"Mitochondrion inner membrane; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9P0J0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFA13","classification":"Not Classified","n_dependent_lines":359,"n_total_lines":1208,"dependency_fraction":0.29718543046357615},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDUFA13","total_profiled":1310},"omim":[{"mim_id":"618855","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44; COXPD44","url":"https://www.omim.org/entry/618855"},{"mim_id":"618251","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31","url":"https://www.omim.org/entry/618251"},{"mim_id":"618249","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28","url":"https://www.omim.org/entry/618249"},{"mim_id":"615534","title":"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE DOMAIN-CONTAINING PROTEIN 1; TIMMDC1","url":"https://www.omim.org/entry/615534"},{"mim_id":"614924","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12","url":"https://www.omim.org/entry/614924"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NDUFA13"},"hgnc":{"alias_symbol":["CGI-39","CDA016","GRIM-19","GRIM19","B16.6"],"prev_symbol":[]},"alphafold":{"accession":"Q9P0J0","domains":[{"cath_id":"1.20.5","chopping":"35-100","consensus_level":"high","plddt":97.8345,"start":35,"end":100}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P0J0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P0J0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P0J0-F1-predicted_aligned_error_v6.png","plddt_mean":93.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFA13","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFA13"},"sequence":{"accession":"Q9P0J0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9P0J0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9P0J0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P0J0"}},"corpus_meta":[{"pmid":"11522775","id":"PMC_11522775","title":"GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I).","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11522775","citation_count":205,"is_preprint":false},{"pmid":"12628925","id":"PMC_12628925","title":"GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12628925","citation_count":197,"is_preprint":false},{"pmid":"23271731","id":"PMC_23271731","title":"The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23271731","citation_count":184,"is_preprint":false},{"pmid":"10924506","id":"PMC_10924506","title":"Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10924506","citation_count":182,"is_preprint":false},{"pmid":"15367666","id":"PMC_15367666","title":"GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15367666","citation_count":177,"is_preprint":false},{"pmid":"15841082","id":"PMC_15841082","title":"Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.","date":"2005","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15841082","citation_count":159,"is_preprint":false},{"pmid":"12867595","id":"PMC_12867595","title":"The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12867595","citation_count":150,"is_preprint":false},{"pmid":"15753091","id":"PMC_15753091","title":"GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15753091","citation_count":112,"is_preprint":false},{"pmid":"22393233","id":"PMC_22393233","title":"GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22393233","citation_count":91,"is_preprint":false},{"pmid":"18223232","id":"PMC_18223232","title":"Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18223232","citation_count":83,"is_preprint":false},{"pmid":"16732315","id":"PMC_16732315","title":"A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16732315","citation_count":81,"is_preprint":false},{"pmid":"18287540","id":"PMC_18287540","title":"GRIM-19 is essential for maintenance of mitochondrial membrane potential.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18287540","citation_count":78,"is_preprint":false},{"pmid":"12163600","id":"PMC_12163600","title":"Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.","date":"2002","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12163600","citation_count":70,"is_preprint":false},{"pmid":"29078279","id":"PMC_29078279","title":"Electron leak from NDUFA13 within mitochondrial complex I attenuates ischemia-reperfusion injury via dimerized STAT3.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29078279","citation_count":51,"is_preprint":false},{"pmid":"30537081","id":"PMC_30537081","title":"GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30537081","citation_count":48,"is_preprint":false},{"pmid":"20478305","id":"PMC_20478305","title":"Upregulation of the GRIM-19 gene suppresses invasion and metastasis of human gastric cancer SGC-7901 cell line.","date":"2010","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/20478305","citation_count":45,"is_preprint":false},{"pmid":"25901006","id":"PMC_25901006","title":"Mutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25901006","citation_count":44,"is_preprint":false},{"pmid":"22665480","id":"PMC_22665480","title":"Function of GRIM-19, a mitochondrial respiratory chain complex I protein, in innate immunity.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22665480","citation_count":40,"is_preprint":false},{"pmid":"17616678","id":"PMC_17616678","title":"Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17616678","citation_count":39,"is_preprint":false},{"pmid":"17297443","id":"PMC_17297443","title":"GRIM-19 associates with the serine protease HtrA2 for promoting cell death.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17297443","citation_count":36,"is_preprint":false},{"pmid":"27659873","id":"PMC_27659873","title":"GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.","date":"2016","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27659873","citation_count":34,"is_preprint":false},{"pmid":"24145455","id":"PMC_24145455","title":"Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24145455","citation_count":34,"is_preprint":false},{"pmid":"32770429","id":"PMC_32770429","title":"Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop.","date":"2020","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/32770429","citation_count":33,"is_preprint":false},{"pmid":"10926209","id":"PMC_10926209","title":"Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.","date":"2000","source":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","url":"https://pubmed.ncbi.nlm.nih.gov/10926209","citation_count":33,"is_preprint":false},{"pmid":"20682646","id":"PMC_20682646","title":"Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.","date":"2010","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/20682646","citation_count":32,"is_preprint":false},{"pmid":"30415005","id":"PMC_30415005","title":"Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30415005","citation_count":32,"is_preprint":false},{"pmid":"33174032","id":"PMC_33174032","title":"Metformin protects high glucose‑cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33174032","citation_count":29,"is_preprint":false},{"pmid":"23580587","id":"PMC_23580587","title":"GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23580587","citation_count":29,"is_preprint":false},{"pmid":"21827581","id":"PMC_21827581","title":"Downregulation of GRIM-19 promotes growth and migration of human glioma cells.","date":"2011","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/21827581","citation_count":28,"is_preprint":false},{"pmid":"22105514","id":"PMC_22105514","title":"Depletion of GRIM-19 accelerates hepatocellular carcinoma invasion via inducing EMT and loss of contact inhibition.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22105514","citation_count":28,"is_preprint":false},{"pmid":"26769301","id":"PMC_26769301","title":"Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis.","date":"2016","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/26769301","citation_count":27,"is_preprint":false},{"pmid":"22492280","id":"PMC_22492280","title":"Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.","date":"2012","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22492280","citation_count":27,"is_preprint":false},{"pmid":"21664299","id":"PMC_21664299","title":"GRIM-19 function in cancer development.","date":"2011","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/21664299","citation_count":26,"is_preprint":false},{"pmid":"17823279","id":"PMC_17823279","title":"Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.","date":"2007","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17823279","citation_count":26,"is_preprint":false},{"pmid":"23386605","id":"PMC_23386605","title":"Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23386605","citation_count":26,"is_preprint":false},{"pmid":"25575809","id":"PMC_25575809","title":"Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25575809","citation_count":25,"is_preprint":false},{"pmid":"17928352","id":"PMC_17928352","title":"The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.","date":"2007","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17928352","citation_count":25,"is_preprint":false},{"pmid":"12433281","id":"PMC_12433281","title":"Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.","date":"2002","source":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","url":"https://pubmed.ncbi.nlm.nih.gov/12433281","citation_count":25,"is_preprint":false},{"pmid":"31304451","id":"PMC_31304451","title":"OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma.","date":"2019","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/31304451","citation_count":24,"is_preprint":false},{"pmid":"23124042","id":"PMC_23124042","title":"GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23124042","citation_count":24,"is_preprint":false},{"pmid":"25455534","id":"PMC_25455534","title":"Expression of GRIM-19 in missed abortion and possible pathogenesis.","date":"2014","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/25455534","citation_count":23,"is_preprint":false},{"pmid":"23618357","id":"PMC_23618357","title":"Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas.","date":"2013","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23618357","citation_count":23,"is_preprint":false},{"pmid":"21765936","id":"PMC_21765936","title":"GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21765936","citation_count":22,"is_preprint":false},{"pmid":"36990300","id":"PMC_36990300","title":"Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-кB axis.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36990300","citation_count":22,"is_preprint":false},{"pmid":"27167343","id":"PMC_27167343","title":"Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27167343","citation_count":21,"is_preprint":false},{"pmid":"29741731","id":"PMC_29741731","title":"Expression of GRIM-19 in unexplained recurrent spontaneous abortion and possible pathogenesis.","date":"2018","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/29741731","citation_count":20,"is_preprint":false},{"pmid":"18156812","id":"PMC_18156812","title":"GRIM-19 in Health and Disease.","date":"2008","source":"Advances in anatomic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18156812","citation_count":20,"is_preprint":false},{"pmid":"26810068","id":"PMC_26810068","title":"GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26810068","citation_count":19,"is_preprint":false},{"pmid":"17626740","id":"PMC_17626740","title":"[Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].","date":"2007","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17626740","citation_count":19,"is_preprint":false},{"pmid":"24133585","id":"PMC_24133585","title":"Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo.","date":"2013","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24133585","citation_count":18,"is_preprint":false},{"pmid":"27677346","id":"PMC_27677346","title":"Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways.","date":"2016","source":"Journal of drug targeting","url":"https://pubmed.ncbi.nlm.nih.gov/27677346","citation_count":18,"is_preprint":false},{"pmid":"27391226","id":"PMC_27391226","title":"GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.","date":"2016","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27391226","citation_count":17,"is_preprint":false},{"pmid":"27258062","id":"PMC_27258062","title":"Grim19 Attenuates DSS Induced Colitis in an Animal Model.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27258062","citation_count":17,"is_preprint":false},{"pmid":"19151760","id":"PMC_19151760","title":"GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19151760","citation_count":17,"is_preprint":false},{"pmid":"37353174","id":"PMC_37353174","title":"Metformin suppresses cardiac fibroblast proliferation under high-glucose conditions via regulating the mitochondrial complex I protein Grim-19 involved in the Sirt1/Stat3 signaling pathway.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37353174","citation_count":17,"is_preprint":false},{"pmid":"22573109","id":"PMC_22573109","title":"Expression and clinical significance of GRIM-19 in lung cancer.","date":"2012","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22573109","citation_count":16,"is_preprint":false},{"pmid":"25550785","id":"PMC_25550785","title":"Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25550785","citation_count":16,"is_preprint":false},{"pmid":"27789183","id":"PMC_27789183","title":"Expression of NDUFA13 in asthenozoospermia and possible pathogenesis.","date":"2016","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/27789183","citation_count":15,"is_preprint":false},{"pmid":"32722639","id":"PMC_32722639","title":"Novel NDUFA13 Mutations Associated with OXPHOS Deficiency and Leigh Syndrome: A Second Family Report.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32722639","citation_count":15,"is_preprint":false},{"pmid":"20505682","id":"PMC_20505682","title":"Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues.","date":"2010","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20505682","citation_count":14,"is_preprint":false},{"pmid":"22580637","id":"PMC_22580637","title":"Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.","date":"2012","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/22580637","citation_count":14,"is_preprint":false},{"pmid":"27101310","id":"PMC_27101310","title":"High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27101310","citation_count":14,"is_preprint":false},{"pmid":"17523870","id":"PMC_17523870","title":"The IFN-beta and retinoic acid-induced cell death regulator GRIM-19 is upregulated during focal cerebral ischemia.","date":"2007","source":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","url":"https://pubmed.ncbi.nlm.nih.gov/17523870","citation_count":14,"is_preprint":false},{"pmid":"22431538","id":"PMC_22431538","title":"Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid.","date":"2012","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22431538","citation_count":13,"is_preprint":false},{"pmid":"33467683","id":"PMC_33467683","title":"GRIM19 Impedes Obesity by Regulating Inflammatory White Fat Browning and Promoting Th17/Treg Balance.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33467683","citation_count":12,"is_preprint":false},{"pmid":"34907600","id":"PMC_34907600","title":"GRIM-19 is a target of mycobacterial Zn2+ metalloprotease 1 and indispensable for NLRP3 inflammasome activation.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34907600","citation_count":12,"is_preprint":false},{"pmid":"20595633","id":"PMC_20595633","title":"Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.","date":"2010","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20595633","citation_count":12,"is_preprint":false},{"pmid":"18179744","id":"PMC_18179744","title":"Differential effects of all-trans retinoic acid on the growth of human keratinocytes and mouth carcinoma epidermoid cultures. Involvement of GRIM-19 and complex I of the respiratory chain.","date":"2007","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18179744","citation_count":12,"is_preprint":false},{"pmid":"34461110","id":"PMC_34461110","title":"GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34461110","citation_count":11,"is_preprint":false},{"pmid":"36387896","id":"PMC_36387896","title":"Grim-19 deficiency promotes decidual macrophage autophagy in recurrent spontaneous abortion.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36387896","citation_count":10,"is_preprint":false},{"pmid":"30032449","id":"PMC_30032449","title":"Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.","date":"2018","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30032449","citation_count":10,"is_preprint":false},{"pmid":"27346638","id":"PMC_27346638","title":"GRIM-19, a gene associated with retinoid-interferon-induced mortality, affects endometrial receptivity and embryo implantation.","date":"2017","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/27346638","citation_count":10,"is_preprint":false},{"pmid":"20640890","id":"PMC_20640890","title":"The cell death regulator GRIM-19 is involved in HIV-1 induced T-cell apoptosis.","date":"2010","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/20640890","citation_count":10,"is_preprint":false},{"pmid":"30005830","id":"PMC_30005830","title":"Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30005830","citation_count":10,"is_preprint":false},{"pmid":"24899100","id":"PMC_24899100","title":"Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24899100","citation_count":10,"is_preprint":false},{"pmid":"39643607","id":"PMC_39643607","title":"GRIM-19-mediated induction of mitochondrial STAT3 alleviates systemic sclerosis by inhibiting fibrosis and Th2/Th17 cells.","date":"2024","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39643607","citation_count":9,"is_preprint":false},{"pmid":"31527330","id":"PMC_31527330","title":"GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.","date":"2019","source":"Bioscience trends","url":"https://pubmed.ncbi.nlm.nih.gov/31527330","citation_count":9,"is_preprint":false},{"pmid":"39158709","id":"PMC_39158709","title":"SGK3 deficiency in macrophages suppresses angiotensin II-induced cardiac remodeling via regulating Ndufa13-mediated mitochondrial oxidative stress.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/39158709","citation_count":8,"is_preprint":false},{"pmid":"38974954","id":"PMC_38974954","title":"Mitochondrial GRIM19 Loss Induces Liver Fibrosis through NLRP3/IL33 Activation via Reactive Oxygen Species/NF-кB Signaling.","date":"2024","source":"Journal of clinical and translational hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/38974954","citation_count":8,"is_preprint":false},{"pmid":"25242535","id":"PMC_25242535","title":"Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25242535","citation_count":8,"is_preprint":false},{"pmid":"28926927","id":"PMC_28926927","title":"GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28926927","citation_count":8,"is_preprint":false},{"pmid":"21184119","id":"PMC_21184119","title":"The knockdown of Ha-GRIM-19 by RNA interference induced programmed cell death.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21184119","citation_count":8,"is_preprint":false},{"pmid":"25351437","id":"PMC_25351437","title":"GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/25351437","citation_count":8,"is_preprint":false},{"pmid":"26458285","id":"PMC_26458285","title":"Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM‑19.","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/26458285","citation_count":8,"is_preprint":false},{"pmid":"26702559","id":"PMC_26702559","title":"The GRIM-19 plays a vital role in shrimps' responses to Vibrio alginolyticus.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26702559","citation_count":8,"is_preprint":false},{"pmid":"23851499","id":"PMC_23851499","title":"GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23851499","citation_count":7,"is_preprint":false},{"pmid":"26011333","id":"PMC_26011333","title":"Expression of GW112 and GRIM-19 in colorectal cancer tissues.","date":"2015","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26011333","citation_count":7,"is_preprint":false},{"pmid":"25955394","id":"PMC_25955394","title":"Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/25955394","citation_count":7,"is_preprint":false},{"pmid":"32896475","id":"PMC_32896475","title":"Interaction of M2 macrophages and endometrial cells induces downregulation of GRIM-19 in endometria of adenomyosis.","date":"2020","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/32896475","citation_count":7,"is_preprint":false},{"pmid":"33163248","id":"PMC_33163248","title":"GRIM-19 Ameliorates Multiple Sclerosis in a Mouse Model of Experimental Autoimmune Encephalomyelitis with Reciprocal Regulation of IFNγ/Th1 and IL-17A/Th17 Cells.","date":"2020","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/33163248","citation_count":7,"is_preprint":false},{"pmid":"19622307","id":"PMC_19622307","title":"[Expression and clinical significance of GRIM-19 in non-small cell lung cancer].","date":"2009","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19622307","citation_count":7,"is_preprint":false},{"pmid":"25174621","id":"PMC_25174621","title":"Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25174621","citation_count":7,"is_preprint":false},{"pmid":"23178692","id":"PMC_23178692","title":"Expression and functional characterization of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) from orange-spotted grouper (Epinephelus coioides).","date":"2012","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23178692","citation_count":7,"is_preprint":false},{"pmid":"34848745","id":"PMC_34848745","title":"Structural exploration with AlphaFold2-generated STAT3α structure reveals selective elements in STAT3α-GRIM-19 interactions involved in negative regulation.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34848745","citation_count":7,"is_preprint":false},{"pmid":"36813832","id":"PMC_36813832","title":"GRIM-19 in asthenozoospermia regulates GC-2 spd cell proliferation, apoptosis and migration.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36813832","citation_count":6,"is_preprint":false},{"pmid":"37118800","id":"PMC_37118800","title":"LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/37118800","citation_count":6,"is_preprint":false},{"pmid":"29074558","id":"PMC_29074558","title":"miR-6743-5p, as a direct upstream regulator of GRIM-19, enhances proliferation and suppresses apoptosis in glioma cells.","date":"2017","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/29074558","citation_count":6,"is_preprint":false},{"pmid":"20717508","id":"PMC_20717508","title":"GRIM-19 Expression and Function in Human Gliomas.","date":"2010","source":"Journal of Korean Neurosurgical Society","url":"https://pubmed.ncbi.nlm.nih.gov/20717508","citation_count":5,"is_preprint":false},{"pmid":"29306209","id":"PMC_29306209","title":"Retinoid interferon-induced mortality19 (GRIM19) inhibits proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29306209","citation_count":5,"is_preprint":false},{"pmid":"30272302","id":"PMC_30272302","title":"Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30272302","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52855,"output_tokens":7071,"usd":0.132315,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16349,"output_tokens":4444,"usd":0.096422,"stage2_stop_reason":"end_turn"},"total_usd":0.228737,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"NDUFA13/GRIM-19 was identified as a bona fide subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I), specifically residing in the hydrophilic arm (subcomplex Iλ). The intact protein is N-terminally acetylated.\",\n      \"method\": \"Denaturing gel electrophoresis of purified complex I subcomplex, tryptic digestion, mass spectrometric peptide sequencing, cDNA cloning, intact protein mass measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical identification from purified complex I by mass spectrometry and sequencing; foundational subunit assignment replicated by subsequent studies\",\n      \"pmids\": [\"11522775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRIM-19 is required for IFN-β/retinoic acid-induced tumor cell death; antisense ablation confers resistance to this death stimulus, and overexpression enhances cell death. The protein was initially characterized as a nuclear protein whose expression is induced by the IFN/RA combination.\",\n      \"method\": \"Antisense cDNA knockout genetic screen, antisense overexpression survival assay, overexpression cell death assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide genetic screen with functional validation by overexpression and antisense in same study; single lab\",\n      \"pmids\": [\"10924506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRIM-19 physically interacts specifically with STAT3 (but not STAT1 or STAT5a) via yeast two-hybrid and co-immunoprecipitation in multiple cell types. GRIM-19 co-localizes with mitochondrial markers, forms perinuclear aggregates with co-expressed STAT3, inhibits STAT3 nuclear translocation stimulated by EGF, and represses STAT3 transcriptional activity and target gene expression.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, domain mapping, confocal microscopy co-localization, reporter gene assay, cell growth suppression assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal methods (Y2H, Co-IP, imaging, reporter), replicated independently by PMID 12867595\",\n      \"pmids\": [\"12628925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRIM-19 binds STAT3 and inhibits its transcriptional activity without blocking ligand-induced STAT3 activation or DNA binding. Mutational analysis showed that the transactivation domain of STAT3, especially residue S727, is required for GRIM-19 binding. GRIM-19 does not inhibit STAT1.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, mutational analysis, transcription reporter assays, EMSA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus mutagenesis plus functional assays, independently replicated across two labs (PMID 12628925 and 12867595)\",\n      \"pmids\": [\"12867595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GRIM-19 is essential for mitochondrial complex I assembly and electron transfer activity. GRIM-19 knockout mice die at embryonic day 9.5, and GRIM-19−/− blastocysts show abnormal mitochondrial structure, morphology, and distribution. Deletion of GRIM-19 destroys complex I assembly and electron transfer activity and influences other respiratory chain complexes.\",\n      \"method\": \"Gene targeting/knockout mouse generation, native complex I activity assays, electron microscopy of mitochondria, blue native PAGE for complex assembly\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse with defined biochemical phenotype (complex I assembly and activity), multiple orthogonal methods, independently consistent with PMID 11522775\",\n      \"pmids\": [\"15367666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GRIM-19 is required for maintenance of mitochondrial membrane potential (ΔΨm). Domain dissection showed the N-terminal sequence contains the mitochondrial localization signal, and deletions of residues 70–80, 90–100, or the entire C-terminal region (70–144) abolished ΔΨm without this effect being shared by other complex I subunits (NDUFA9, NDUFS3). Deletion of the last 10 residues prevented assembly into complex I. A dominant-negative mutant (N-terminal 60 aa + last 10 aa C-terminal) assembled into complex I but failed to maintain ΔΨm and sensitized cells to apoptosis.\",\n      \"method\": \"Deletion/truncation/point mutagenesis, mitochondrial membrane potential assays (JC-1), blue native PAGE for complex I assembly, apoptosis assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with in-cell functional readout (ΔΨm, complex assembly), multiple mutants and controls in single study\",\n      \"pmids\": [\"18287540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KSHV vIRF1 directly interacts with GRIM-19 via its N-terminal region, colocalizes with GRIM-19 in cells, and deregulates GRIM-19-induced apoptosis, conferring resistance to IFN/RA-induced cell death. HPV16 E6 also binds GRIM-19.\",\n      \"method\": \"Yeast two-hybrid assay, co-immunoprecipitation in vivo, in vitro binding assay, confocal colocalization, cell death assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus in vitro binding plus functional death assay; single lab\",\n      \"pmids\": [\"12163600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GRIM-19 interacts with NOD2 in intestinal epithelial cells (HT29) and is required for NF-κB activation downstream of NOD2-mediated recognition of muramyl dipeptide (MDP). GRIM-19 also controls pathogen invasion of intestinal epithelial cells.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation with endogenous NOD2, NF-κB reporter assay, bacterial invasion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous Co-IP, functional NF-κB and invasion assays; single lab\",\n      \"pmids\": [\"15753091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRIM-19 physically interacts with the mitochondrial serine protease HtrA2, augments HtrA2-driven destruction of the antiapoptotic protein XIAP in an IFN/RA-dependent manner, and promotes cell death. The KSHV oncoprotein vIRF1 disrupts this GRIM-19–HtrA2 interaction.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, XIAP degradation assay, cell death assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional substrate (XIAP) assay; single lab\",\n      \"pmids\": [\"17297443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRIM-19 suppresses v-Src-induced oncogenic transformation by down-regulating STAT3-dependent gene expression and also inhibits src-induced tyrosyl phosphorylation of focal adhesion kinase (FAK), paxillin, E-cadherin, and γ-catenin independently of STAT3.\",\n      \"method\": \"Overexpression and shRNA knockdown, in vitro transformation assays, in vivo tumor xenografts, phosphotyrosine immunoblotting\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays in vitro and in vivo with specific molecular readouts; single lab\",\n      \"pmids\": [\"17823279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The HHV-6B U95 immediate-early protein interacts with GRIM-19. This interaction was verified by Co-IP and confocal coimmunolocalization. Silencing U95 by RNAi reduced viral load and abrogated the loss of mitochondrial membrane potential caused by HHV-6B infection.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation, confocal microscopy co-localization, RNA interference knockdown, mitochondrial membrane potential assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus RNAi functional rescue; single lab\",\n      \"pmids\": [\"17928352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GRIM-19 inhibits v-Src-induced cell motility by suppressing podosome formation (cytoskeletal remodeling). The N-terminus of GRIM-19 is critical for this function. Tumor-associated GRIM-19 mutations disrupted inhibition of cell motility independently of STAT3.\",\n      \"method\": \"Overexpression of wild-type and mutant GRIM-19, podosome/actin imaging, cell motility assays, in vivo metastasis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with defined mutants; in vitro and in vivo; single lab\",\n      \"pmids\": [\"19151760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GRIM-19 acts as a chaperone to recruit STAT3 into mitochondria, where STAT3 resides in the inner mitochondrial membrane. In vitro import assays showed GRIM-19 enhances integration of STAT3 into complex I. The S727A mutation in STAT3 reduces its import and assembly even in the presence of GRIM-19.\",\n      \"method\": \"In vitro mitochondrial import assay, mitochondrial fractionation (inner membrane localization), blue native PAGE for complex I assembly, S727A STAT3 mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted import assay plus mutagenesis plus organelle fractionation; multiple orthogonal methods in one study\",\n      \"pmids\": [\"23271731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"During TNF-induced necroptosis, RIPK1-dependent phosphorylation of STAT3 on serine 727 induces STAT3 interaction with GRIM-19, leading to translocation of STAT3 to mitochondria, increased mitochondrial ROS production, and cell death.\",\n      \"method\": \"Co-immunoprecipitation, RIPK1 knockdown/necrostatin-1 inhibition, mitochondrial fractionation, ROS measurement, cell viability assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating STAT3-GRIM-19 interaction conditioned on phosphorylation, with functional knockdown validation; single lab\",\n      \"pmids\": [\"22393233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GRIM-19 heterozygous knockout mice have compromised complex I activity and increased ROS in macrophages. Bacterial infection induces rapid upregulation of GRIM-19 and complex I activity in wild-type macrophages; GRIM-19+/− macrophages have decreased intracellular bacterial killing (defect in phagosome-lysosome fusion) and reduced proinflammatory cytokine production (IL-1, IL-12, IL-6, IFN-γ).\",\n      \"method\": \"Heterozygous knockout mouse, complex I activity assay, ROS measurement, bacterial killing assay, phagosome fusion assay, ELISA for cytokines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO model with multiple defined biochemical and cellular phenotypes; mechanistically links complex I activity to innate immune function\",\n      \"pmids\": [\"22665480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRIM-19 disrupts the HPV E6/E6AP complex by physically interacting (via its N-terminus) with both E6 and E6AP; GRIM-19 promotes E6AP ubiquitination and degradation, thereby protecting p53 from E6-mediated degradation and inducing apoptosis in cervical cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down assay, competition pull-down, in vivo and in vitro ubiquitination assay, xenograft mouse model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus GST pull-down plus ubiquitination assay plus in vivo validation; single lab\",\n      \"pmids\": [\"21765936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tumor-derived somatic mutations in GRIM-19 (L71P, L91P, A95T) significantly impair GRIM-19's ability to associate with STAT3, block gene expression, suppress cellular transformation, and prevent metastasis in head and neck tumors.\",\n      \"method\": \"Tumor sequencing, co-immunoprecipitation with mutants, reporter assays, in vitro transformation assay, in vivo tumor growth and metastasis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis with multiple readouts in vitro and in vivo; single lab\",\n      \"pmids\": [\"23386605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Monoallelic (heterozygous) loss of GRIM-19 in mouse skin promotes chemical carcinogenesis and formation of invasive squamous cell carcinomas, with high Stat3 activity, increased Stat3-responsive gene expression, mitochondrial electron transport dysfunction, failure to assemble ETC complexes, and altered glycolytic gene expression.\",\n      \"method\": \"Conditional skin-specific knockout mouse, chemical carcinogenesis protocol, blue native PAGE for ETC assembly, STAT3 reporter assay, metabolic gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional KO with multiple mechanistic readouts; defines haploinsufficiency as tumor-suppressor mechanism\",\n      \"pmids\": [\"24145455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRIM-19 downregulation in glioblastoma promotes HIF1α accumulation in a STAT3-dependent manner; GRIM-19 loss allows STAT3 to act as a competitive inhibitor of pVHL–HIF1α interaction, preventing pVHL-mediated ubiquitination and proteasomal degradation of HIF1α, thereby promoting metabolic reprogramming toward glycolysis.\",\n      \"method\": \"shRNA knockdown, overexpression, co-immunoprecipitation (STAT3–pVHL–HIF1α), proteasome inhibitor treatment, HIF1α stability assay, metabolic assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating molecular complex plus functional degradation assay; single lab\",\n      \"pmids\": [\"23580587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A germline pathogenic mutation in NDUFA13/GRIM-19 causes drastic reduction in complex I enzymatic activity in patient muscle biopsies and decreased complex I-driven respiration in fibroblasts (with preserved complex II, III, IV activities). Western blots showed decreased NDUFA13 protein, complex I holoenzyme, and supercomplexes in mitochondrial fractions. Silencing NDUFA13 in control cells reproduced the complex I instability.\",\n      \"method\": \"Next-generation sequencing, complex I enzymatic activity assay, oxygen consumption in fibroblasts, blue native PAGE/western blot for complex I and supercomplexes, siRNA knockdown in control cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biochemical activity measurements in patient tissue plus siRNA phenocopy; multiple orthogonal methods\",\n      \"pmids\": [\"25901006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cardiac-specific heterozygous knockout of NDUFA13 in mice yields normal cardiac function at baseline but resistance to ischemia-reperfusion injury. At basal state, cHet mice exhibit higher cytosolic H2O2 (but not mitochondrial). This H2O2 acts as a second messenger driving STAT3 dimerization and antiapoptotic signaling, resulting in suppressed superoxide burst and decreased infarct size during I/R.\",\n      \"method\": \"Cardiac-specific tamoxifen-inducible NDUFA13 KO mouse, I/R model, oxygen consumption rate assay, H2O2 measurement (cytosolic vs mitochondrial), STAT3 dimerization assay, infarct size measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo cardiac KO with mechanistic ROS/STAT3 signaling dissection using multiple orthogonal methods; single lab\",\n      \"pmids\": [\"29078279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GRIM-19 induces apoptosis in colorectal cancer cells in a p53-dependent manner via the SIRT7/PCAF/MDM2 axis: GRIM-19 activates SIRT7, which triggers PCAF-mediated ubiquitination of MDM2, stabilizing p53 protein.\",\n      \"method\": \"Overexpression/knockdown, co-immunoprecipitation, ubiquitination assay, flow cytometry for apoptosis, in vivo xenograft\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus in vivo validation; single lab\",\n      \"pmids\": [\"34461110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GRIM19 co-localizes with Bcl-xL in the mitochondria of bladder cancer cells. GRIM19 overexpression promotes Bcl-xL polyubiquitination and degradation via p38-MAPK and JNK pathways, contributing to cisplatin sensitization; inhibition of Bcl-xL rescues GRIM19 deficiency-caused cisplatin resistance.\",\n      \"method\": \"Co-immunoprecipitation, confocal colocalization, ubiquitination assay, kinase inhibitor experiments (p38/JNK), stable GRIM19 knockdown cell lines, xenograft mouse model\",\n      \"journal\": \"Cancer chemotherapy and pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating GRIM19–Bcl-xL interaction plus ubiquitination assay plus pharmacological pathway dissection; single lab\",\n      \"pmids\": [\"30032449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GRIM-19/NDUFA13 is a binding partner of mycobacterial Zmp1 metalloprotease. GRIM-19 is required for NLRP3 inflammasome activation: CRISPR/Cas9 knockout of GRIM-19 in macrophages abolishes IL-1β production in response to mycobacterial infection and to NLRP3 activators (ATP, nigericin). GRIM-19 is required for mitochondrial ROS generation and NLRP3-dependent caspase-1 activation. Forced Zmp1 expression or GRIM-19 loss decreases mitochondrial membrane potential.\",\n      \"method\": \"CRISPR/Cas9 knockout macrophage line, IL-1β ELISA, caspase-1 activity assay, mitochondrial ROS measurement, mitochondrial membrane potential assay, Zmp1 overexpression\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with multiple defined biochemical phenotypes; mechanistically positions GRIM-19 upstream of NLRP3/caspase-1/IL-1β pathway\",\n      \"pmids\": [\"34907600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRIM-19 deficiency in gastric cancer cells triggers ROS-dependent activation of the NRF2-HO-1 axis, which drives metastasis. HO-1 inhibition reverses both GRIM-19 deficiency-driven NRF2 activation and NRF2 activator-induced NRF2 signaling via a positive-feedback NRF2-HO-1 loop.\",\n      \"method\": \"CRISPR/Cas9 lentivirus gene editing, in vivo metastasis mouse models, ROS inhibitor/NRF2 inhibitor/HO-1 inhibitor pharmacological intervention, reporter gene assay, flow cytometry\",\n      \"journal\": \"Gastric cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO plus pharmacological pathway dissection plus in vivo validation; single lab\",\n      \"pmids\": [\"32770429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A structural motif in the N-terminus of GRIM-19 is required for its interaction with STAT3 and antitumor activity; disruption of specific amino acids within this motif (including a clinically observed mutation) weakens STAT3 binding and abolishes growth-suppressive function.\",\n      \"method\": \"Mutational analysis, co-immunoprecipitation, reporter assays, transformation assays\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis with binding and functional readouts; single lab\",\n      \"pmids\": [\"20595633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GRIM-19 knockdown in Jurkat cells increases intracellular ROS and p-mTOR expression; NAC (ROS inhibitor) reverses p-mTOR upregulation from GRIM-19 loss, placing GRIM-19 upstream of a ROS–mTOR signaling axis that regulates Treg/Th17 balance.\",\n      \"method\": \"siRNA knockdown, intracellular ROS measurement (DCFH-DA), western blot for p-mTOR, NAC rescue experiment\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, indirect pathway inference via ROS/NAC rescue; limited mechanistic depth\",\n      \"pmids\": [\"29741731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GRIM-19 overexpression increases mitochondrial STAT3 (mitoSTAT3) levels, induces mitophagy, and alleviates fibrosis in an SSc model. GRIM-19 directly binds STAT3 and recruits it to mitochondria via the mitochondrial importer Tom20.\",\n      \"method\": \"Overexpression in murine SSc model, mitochondrial STAT3 quantification, mitophagy assay, Tom20 co-immunoprecipitation, in vivo bleomycin SSc model\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP (Tom20), in vivo model plus in vitro mechanistic assays; single lab\",\n      \"pmids\": [\"39643607\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFA13/GRIM-19 is an essential accessory subunit of the mitochondrial respiratory chain complex I (residing in the hydrophilic arm) that is required for complex I assembly, electron transfer activity, and maintenance of mitochondrial membrane potential; beyond its bioenergetic role, it functions as a specific inhibitor of STAT3 by direct physical interaction (via its N-terminal domain binding the STAT3 transactivation domain, dependent on S727) that blocks STAT3 nuclear translocation and transcriptional activity, and also acts as a chaperone recruiting STAT3 to the inner mitochondrial membrane via Tom20; it additionally interacts with HtrA2 to augment XIAP degradation, with NOD2 to enable NF-κB activation, and is required for mitochondrial ROS generation upstream of NLRP3 inflammasome/caspase-1/IL-1β activation, while tumor-derived mutations in its N-terminal structural motif selectively abrogate STAT3 binding and anti-oncogenic functions.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NDUFA13/GRIM-19 is an essential accessory subunit of the hydrophilic arm of mitochondrial NADH:ubiquinone oxidoreductase (complex I) that couples respiratory chain bioenergetics to apoptotic and inflammatory signaling [#0, #4]. As a structural subunit it is required for complex I assembly, electron transfer activity, and maintenance of the mitochondrial membrane potential, with its N-terminal sequence providing the mitochondrial localization signal and its C-terminal region required for both assembly into complex I and membrane potential maintenance; its loss destabilizes complex I holoenzyme and supercomplexes and is embryonic-lethal in mice [#4, #5, #19]. A germline pathogenic NDUFA13 mutation causes an isolated complex I deficiency in patients, with reduced NDUFA13 protein, complex I, and supercomplexes [#19]. Beyond bioenergetics, GRIM-19 was identified as a mediator of IFN-\\u03b2/retinoic acid-induced tumor cell death [#1] and functions as a specific inhibitor of STAT3: it binds STAT3 (but not STAT1 or STAT5a) through a structural motif in its N-terminus that engages the STAT3 transactivation domain in an S727-dependent manner, blocking STAT3 nuclear translocation and transcriptional activity without preventing STAT3 activation or DNA binding [#2, #3, #25]. It also acts as a chaperone recruiting STAT3 into the inner mitochondrial membrane via Tom20 and integrating it into complex I [#12, #27]. Through these activities GRIM-19 functions as a tumor suppressor: monoallelic loss promotes STAT3-driven carcinogenesis, and tumor-derived N-terminal mutations (L71P, L91P, A95T) selectively abrogate STAT3 binding and anti-oncogenic functions [#16, #17]. GRIM-19 additionally couples complex I-dependent mitochondrial ROS to innate immunity, being required for NLRP3 inflammasome/caspase-1/IL-1\\u03b2 activation and bactericidal macrophage function [#14, #23], and engages partners including HtrA2 (augmenting XIAP degradation) and NOD2 (enabling NF-\\u03baB activation) [#7, #8]. Multiple viral oncoproteins (KSHV vIRF1, HPV16 E6, HHV-6B U95) target GRIM-19 to subvert its apoptotic and bioenergetic functions [#6, #10, #15].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Before any molecular role was known, a functional screen established GRIM-19 as a required mediator of cytokine-induced tumor cell death, framing it as a candidate cell-death effector rather than a housekeeping protein.\",\n      \"evidence\": \"Antisense cDNA knockout genetic screen with overexpression and survival validation in IFN-\\u03b2/retinoic acid-treated tumor cells\",\n      \"pmids\": [\"10924506\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the biochemical activity underlying death induction\", \"Initial nuclear localization claim not reconciled with later mitochondrial assignment\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Direct biochemical identification placed GRIM-19 in the respiratory machinery, establishing it as a bona fide complex I subunit in the hydrophilic arm.\",\n      \"evidence\": \"Mass spectrometric sequencing of purified bovine complex I subcomplex I\\u03bb plus cDNA cloning and intact mass measurement\",\n      \"pmids\": [\"11522775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test whether the subunit is required for assembly or activity\", \"Connection to the death phenotype not yet made\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Two independent studies converged to define GRIM-19 as a specific STAT3 inhibitor, mapping the interaction to the STAT3 transactivation domain and S727 and showing repression of transcription without blocking activation or DNA binding.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation, domain/point mutagenesis, reporter assays, EMSA and confocal imaging across multiple cell types\",\n      \"pmids\": [\"12628925\", \"12867595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how a complex I subunit accesses STAT3\", \"Structural basis of the S727-dependent interaction not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Knockout demonstrated GRIM-19 is indispensable for complex I assembly and electron transfer and for embryonic viability, proving its bioenergetic role is essential rather than accessory.\",\n      \"evidence\": \"Gene-targeted knockout mouse (E9.5 lethality), blue native PAGE, native activity assays, and EM of blastocyst mitochondria\",\n      \"pmids\": [\"15367666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate bioenergetic from STAT3-regulatory contributions to phenotype\", \"Mechanism of assembly support not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Domain dissection separated GRIM-19's assembly role from membrane-potential maintenance, localizing the mitochondrial targeting signal to the N-terminus and identifying regions whose loss abolishes \\u0394\\u03a8m and sensitizes cells to apoptosis.\",\n      \"evidence\": \"Systematic deletion/truncation/point mutagenesis with JC-1 \\u0394\\u03a8m readout, blue native PAGE, and apoptosis assays including a dominant-negative mutant\",\n      \"pmids\": [\"18287540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular basis by which the C-terminal region maintains \\u0394\\u03a8m\", \"Did not link \\u0394\\u03a8m maintenance to specific downstream signaling\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Reconstituted import showed GRIM-19 chaperones STAT3 into the inner mitochondrial membrane and complex I, providing the physical mechanism by which the two interacting proteins co-reside in mitochondria.\",\n      \"evidence\": \"In vitro mitochondrial import assay, inner-membrane fractionation, blue native PAGE, and S727A STAT3 mutagenesis\",\n      \"pmids\": [\"23271731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of mitochondrial STAT3 on complex I activity not quantified\", \"Import receptor not identified in this study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"GRIM-19 was placed in a death-signaling axis in which RIPK1-dependent S727 phosphorylation drives STAT3-GRIM-19 association, mitochondrial STAT3 translocation, and ROS-dependent necroptosis.\",\n      \"evidence\": \"Co-IP conditioned on phosphorylation, RIPK1 knockdown/necrostatin-1, mitochondrial fractionation, ROS and viability assays\",\n      \"pmids\": [\"22393233\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; reciprocal validation of the phospho-dependent interaction limited\", \"Source of mitochondrial ROS not mechanistically isolated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A heterozygous knockout linked GRIM-19 dosage to innate immune competence, connecting reduced complex I activity and elevated macrophage ROS to defective bacterial killing and cytokine output.\",\n      \"evidence\": \"GRIM-19+/\\u2212 mouse macrophages with complex I activity, ROS, bacterial killing, phagosome-lysosome fusion, and cytokine ELISA assays\",\n      \"pmids\": [\"22665480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the downstream inflammasome step linking ROS to cytokines\", \"Did not separate STAT3-dependent from bioenergetic contributions\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"In vivo and patient-derived genetics established GRIM-19 as a haploinsufficient tumor suppressor, with monoallelic loss promoting STAT3-driven carcinogenesis and tumor-derived N-terminal mutations selectively crippling STAT3 binding and anti-oncogenic function.\",\n      \"evidence\": \"Conditional skin knockout with chemical carcinogenesis, tumor sequencing of L71P/L91P/A95T mutants, co-IP, reporter, transformation and metastasis assays\",\n      \"pmids\": [\"24145455\", \"23386605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of ETC dysfunction versus STAT3 derepression to tumorigenesis not resolved\", \"Whether mutations affect bioenergetic function not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRISPR knockout positioned GRIM-19 upstream of the NLRP3 inflammasome, showing it is required for mitochondrial ROS generation, caspase-1 activation, and IL-1\\u03b2 production, and that the mycobacterial protease Zmp1 targets it.\",\n      \"evidence\": \"CRISPR/Cas9 macrophage knockout with IL-1\\u03b2 ELISA, caspase-1 activity, mitochondrial ROS and \\u0394\\u03a8m assays, and Zmp1 overexpression\",\n      \"pmids\": [\"34907600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical link between GRIM-19/complex I ROS and NLRP3 not structurally defined\", \"Whether Zmp1 binding disrupts complex I or STAT3 functions untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"GRIM-19 was shown to recruit STAT3 to mitochondria via the import receptor Tom20 and to induce mitophagy in a fibrosis model, refining the chaperone mechanism with a named receptor.\",\n      \"evidence\": \"Overexpression in a murine systemic sclerosis model, Tom20 co-IP, mitochondrial STAT3 quantification, and mitophagy assays\",\n      \"pmids\": [\"39643607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; reciprocal Tom20 validation limited\", \"Link between mitoSTAT3 recruitment and mitophagy induction mechanistically incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GRIM-19's structural role in complex I, its STAT3-sequestering activity, and its control of mitochondrial ROS are quantitatively partitioned across bioenergetic, apoptotic, and inflammatory outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the GRIM-19\\u2013STAT3 interface\", \"Causal hierarchy between complex I dysfunction and each downstream signaling branch not established\", \"Whether disease and tumor mutations act primarily through STAT3 or bioenergetics undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 4, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 25]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [12, 27]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 4, 12]},\n      {\"term_id\": \"GO:0005743\", \"supporting_discovery_ids\": [5, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1428517\", \"supporting_discovery_ids\": [0, 4, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 8, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14, 23]}\n    ],\n    \"complexes\": [\"mitochondrial respiratory chain complex I\"],\n    \"partners\": [\"STAT3\", \"HtrA2\", \"NOD2\", \"TOMM20\", \"BCL2L1\", \"UBE3A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}